Literature DB >> 3921905

Acoustic tumors: preoperative measurement and correlation with postoperative facial nerve function.

H R Ruth, C M Luetje, C K Whittaker.   

Abstract

The cases of 67 patients consecutively operated on for acoustic tumors are reported. Preoperative records consist of tumor size and the position of the fourth ventricle on computerized tomography (CT) scans. An analysis is made of the immediate postoperative and current function of the facial nerves. There is a statistically significant relationship between the number of weak or paralyzed seventh nerves and displacement of the fourth ventricle (P less than .05). It is now possible to accurately measure acoustic tumors on preoperative CT scans. The position of the fourth ventricle can also be clearly seen. The current standard of diagnosis and management of acoustic tumors should include a cursor measurement of tumor size on CT scan and a notation of the position of the fourth ventricle. Adoption of this method of reporting will permit meaningful evaluation of treatment for acoustic tumors. This analysis illustrates the importance of accurate measurements in reporting and evaluating surgical results.

Entities:  

Mesh:

Year:  1985        PMID: 3921905     DOI: 10.1177/019459988509300206

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Anterior Extension of Tumor is as Important as Tumor Size to Facial Nerve Outcome and Extent of Resection for Vestibular Schwannomas.

Authors:  Ricky H Wong; William R Copeland; Jeffrey T Jacob; Sananthan Sivakanthan; Jamie J Van Gompel; Harry van Loveren; Michael J Link; Siviero Agazzi
Journal:  J Neurol Surg B Skull Base       Date:  2017-07-25

2.  Radiological and Clinical Factors Predicting the Facial Nerve Outcome following Retrosigmoid Approach for Large Vestibular Schwannomas (VSs).

Authors:  Mayur Sharma; Ashish Sonig; Sudheer Ambekar; Anil Nanda
Journal:  J Neurol Surg B Skull Base       Date:  2013-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.